Related Experiment Video
Updated: Aug 15, 2025

Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin
Published on: May 6, 2018
Immune checkpoint inhibitor induced nephrotoxicity: An ongoing challenge
Martina Catalano1, Giandomenico Roviello2, Ilaria Camilla Galli3
1School of Human Health Sciences, University of Florence, Florence, Italy.
Immune checkpoint inhibitors (ICIs) offer cancer treatment advances but can cause severe immune-related adverse events (irAEs). This review focuses on ICI-induced nephrotoxicity, its challenges, and future research directions.
Area of Science:
- Oncology
- Immunology
- Nephrology
Background:
- Immune checkpoint inhibitors (ICIs) have transformed cancer therapy.
- Immune-related adverse events (irAEs) are significant toxicities associated with ICIs.
- Nephrotoxicity is a less common but serious irAE, often difficult to diagnose.
Purpose of the Study:
- To review the current understanding of ICI-induced nephrotoxicity.
- To evaluate the challenges in diagnosing and managing kidney toxicity from ICIs.
- To discuss future perspectives in the field of ICI-related kidney injury.
Main Methods:
- Literature review of current knowledge on ICI-induced nephrotoxicity.
- Analysis of diagnostic challenges and management strategies.
- Evaluation of existing data and identification of research gaps.
Main Results:
- ICI-induced nephrotoxicity is underdiagnosed due to subtle or non-specific symptoms.
- Standard management involves discontinuing ICIs and/or using corticosteroids.
- Limited data exists on specific mechanisms and long-term outcomes of ICI nephrotoxicity.
Conclusions:
- ICI-induced nephrotoxicity requires greater clinical attention and improved diagnostic tools.
- Further research is needed to elucidate mechanisms, refine management, and predict risk.
- Optimizing the use of ICIs while mitigating kidney-related irAEs is crucial for patient care.
Related Concept Videos
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Nephrotic Syndrome I : Introduction
Kidney Transplant III: Nursing Management
Chronic Kidney Disease III: Interprofessional Care
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Chronic Kidney Disease IV: Nursing Management

